Trials that use: Covariate adjustment
5,848 results
- Therapeutic Effects of “Ibuprofen, Diphenhydramine and Aluminium MgS” on Recurrent Aphthous Stomatitis: Complete Statistical AnalysisIndependent statistical analysis of Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients: Complete Statistical AnalysisIndependent statistical analysis of Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Therapy for Migraine Prevention in Children 6-11 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Therapy for Migraine Prevention in Children 6-11 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04050293).
- Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Theta Burst Stimulation for Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Theta Burst Stimulation for Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03288779).
- Thiamine as a Renal Protective Agent in Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Thiamine as a Renal Protective Agent in Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03550794).
- This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- This Is A Study Of Bioavailability And Food Effect For Fesoterodine.: Complete Statistical AnalysisIndependent statistical analysis of This Is A Study Of Bioavailability And Food Effect For Fesoterodine.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- This is a Study to Determine the Antidepressant Effects of AZD6765: Complete Statistical AnalysisIndependent statistical analysis of This is a Study to Determine the Antidepressant Effects of AZD6765: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS): Complete Statistical AnalysisIndependent statistical analysis of This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS): primary endpoint results, effect estimate with…
- THORIndependent statistical analysis of A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations: primary endpoint…
- Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations: Complete Statistical AnalysisIndependent statistical analysis of Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction: Complete Statistical AnalysisIndependent statistical analysis of Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- THRIVEIndependent statistical analysis of Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ThriveIndependent statistical analysis of Technology and Family Thriving Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05150990).
- THRIVE: Culturally AdapTed Harm Reduction Intervention: Complete Statistical AnalysisIndependent statistical analysis of THRIVE: Culturally AdapTed Harm Reduction Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06609278).
- THUNDER: Acute Ischemic Stroke Study With the Penumbra System® Including Thunderbolt™ Aspiration Tubing: Complete Statistical AnalysisIndependent statistical analysis of THUNDER: Acute Ischemic Stroke Study With the Penumbra System® Including Thunderbolt™ Aspiration Tubing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Thyroid Function of Pediatric Subjects Following Isovue® Administration: Complete Statistical AnalysisIndependent statistical analysis of Thyroid Function of Pediatric Subjects Following Isovue® Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03779906).
- TIARAIndependent statistical analysis of The Influence of Age on EEG Signals and Consciousness During Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tibial Delayed Healing Pivotal Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Tibial Delayed Healing Pivotal Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01016067).
- TIC-TOCIndependent statistical analysis of Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TICSIndependent statistical analysis of Tick-borne Illness and Clothing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01454414).
- TICTACIndependent statistical analysis of Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TIDE-asthmaIndependent statistical analysis of Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TIGER KidsIndependent statistical analysis of Translational Investigation of Growth and Everyday Routines in Kids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02784509).
- TimeLEAdIndependent statistical analysis of Time Limited Eating in Adolescents (Time LEAd): a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03954223).
- Timing of Antibiotic Prophylaxis for Cesarean Deliveries: Complete Statistical AnalysisIndependent statistical analysis of Timing of Antibiotic Prophylaxis for Cesarean Deliveries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805545).
- Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: Complete Statistical AnalysisIndependent statistical analysis of Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tiotropium / Respimat One Year Study in COPD.: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium / Respimat One Year Study in COPD.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00387088).
- Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tiotropium/Salmeterol Inhalation Powder in COPD: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium/Salmeterol Inhalation Powder in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00668772).
- TIPIndependent statistical analysis of Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05113277).
- TIPIndependent statistical analysis of The Identity Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03772522).
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: primary endpoint results, effect estimate with confidence…
- Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: Complete Statistical AnalysisIndependent statistical analysis of Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TitAINIndependent statistical analysis of A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TIVAIndependent statistical analysis of Targeting Inflammation to Treat Cardiovascular Aging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01775865).
- Tivantinib in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tivantinib in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519414).
- TIVO-1Independent statistical analysis of A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TK112690Independent statistical analysis of Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TL011 in Severe, Active Rheumatoid Arthritis Patients: Complete Statistical AnalysisIndependent statistical analysis of TL011 in Severe, Active Rheumatoid Arthritis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123070).
- TMC114IFD3001 – Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV: Complete Statistical AnalysisIndependent statistical analysis of TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company…
- TMDPACTIndependent statistical analysis of Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036215).
- TMScogModIndependent statistical analysis of Theta Burst Transcranial Magnetic Stimulation of Fronto-parietal Networks: Modulation by Mental State: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TN05Independent statistical analysis of Rituximab in New Onset Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00279305).
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…